Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Haemophilus Influenzae Type B (Hib) Vaccine – Pipeline Assessment and Market Forecasts to 2019The Haemophilus Influenzae Type b (Hib) Vaccine Market is Forecast to Show Low Growth up until 2019
By: Rajesh Gunnam 2011. GlobalData forecasts that the global Hib vaccine market will grow at a CAGR of 2.3% over the next eight years to reach $1,414.9m by 2019. Vaccination programs by the World Health Organization (WHO) have spurted the vaccination coverage rate rendering a high growth rate in the Hib vaccines market in the historical period from 2006 to 2011. The Global Alliance for Vaccines and Immunization (GAVI) their Hib initiative (2005) promoted the use of Hib as a mandatory vaccine in national immunization programs in both developed and developing countries. The Hib vaccine market is expected to show low growth during the forecast period. This is primarily attributed to the availability of an adequate number of safe and effective vaccines in the Hib vaccine market and a high vaccine coverage rate. These vaccines are included in the national immunization programs of the seven major geographies: The market is well served with monovalent vaccines like ActHIB (Sanofi) and PedvaxHIB (Merck). Combination vaccines, such as Pentacel (Sanofi), ComvaxHIB (Merck), are also preferred by vaccine providers as they provide immunity against several infectious childhood diseases with only one shot of vaccine, reducing the discomfort and pain felt by the child during vaccination. Hiberix (GlaxoSmithKline) For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ GlobalData found the unmet need in Hib vaccine market to be low. This may be attributed to the availability of various monovalent and combined vaccines for the prophylaxis of Hib diseases. Also, as these vaccines have a proven efficacy and safety in preventing Hib diseases, they are adequately serving the market. The cost effectiveness of these vaccines is also high as they are mandatory vaccines and are therefore subsidized by the governments. However, in Japan, Hib vaccines were included in the national immunization program in 2008 and are given on request only. The following figure depicts the unmet need in the Hib monovalent vaccine market. GlobalData, the industry analysis specialist, has released its new report, “Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Haemophilus influenzae type B vaccine Therapeutics market. The report identifies the key trends shaping and driving the global Haemophilus influenzae type B vaccine Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Haemophilus influenzae type B vaccine Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com/ For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a global market intelligence services company providing information research and analysis products and services. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number